- +126.0% price growth over the last year
- High gross margin of 79.4%
- Lower volatility than the market (beta 0.35)
X4 Pharmaceuticals Inc. stock upgraded to Buy Candidate
(Updated on Jul 29, 2026)
The X4 Pharmaceuticals Inc. stock price gained 1.78% on the last trading day (Wednesday, 29th Jul 2026), rising from $3.93 to $4.00. During the last trading day the stock fluctuated 4.90% from a day low at $3.88 to a day high of $4.07. The price has been going up and down for this period, and there has been a 2.56% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 868 thousand shares were bought and sold for approximately $3.47 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.99% during the next 3 months and, with a 90% probability hold a price between $3.47 and $4.36 at the end of this 3-month period.
XFOR Signals & Forecast
The X4 Pharmaceuticals Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $3.87 and $4.00. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has risen 8.70%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for X4 Pharmaceuticals Inc. stock
X4 Pharmaceuticals Inc. finds support from accumulated volume at $3.99 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.190 between high and low, or 4.90%. For the last week, the stock has had daily average volatility of 6.75%.
Our recommended stop-loss: $3.84 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 7 days ago.)
Trading Expectations (XFOR) For The Upcoming Trading Day Of Thursday 30th
For the upcoming trading day on Thursday, 30th we expect X4 Pharmaceuticals Inc. to open at $3.98, and during the day (based on 14 day Average True Range), to move between $3.88 and $4.12, which gives a possible trading interval of +/-$0.244 (+/-6.30%) up or down from last closing price. If X4 Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 6.30% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $3.99 (0.25%) than the resistance at $4.02 (0.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
X4 Pharmaceuticals Inc. will release earnings BMO on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.190. We will update the financials statements for X4 Pharmaceuticals Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 17.56% in the first trading day after earnings release.
Is X4 Pharmaceuticals Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score:
3.041
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 30, 2026 - $3.98 ( 0.417%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
XFOR Performance
Trading levels for XFOR
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.17 | 4.33% |
| R2 | 4.10 | 2.52% |
| R1 | 4.06 | 1.40% |
| Price | 4.00 | |
| S1 | 3.91 | -2.23% |
| S2 | 3.87 | -3.35% |
| S3 | 3.79 | -5.17% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.67 | 16.75% |
| R2 | 4.04 | 1.00% |
| R1 | 4.02 | 0.500% |
| Price | 4.00 | |
| S1 | 3.99 | -0.250% |
| S2 | 3.94 | -1.50% |
| S3 | 3.68 | -8.00% |
FAQ
Click here for our free guide on how to buy X4 Pharmaceuticals Inc. Stock.
Buy XFOR